Peginterferon vs. interferon in the treatment of different HCV genotype infections in HIV patients View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-06-17

AUTHORS

S. Zhao, D. Cheng, E. Liu, H. Yu, H. Yang, X. Xue, Y. Chu

ABSTRACT

It remains difficult to achieve high sustained response rates (SVRs) in chronic hepatitis patients coinfected with human immunodeficiency virus (HIV). The aim of this study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing peginterferon with interferon in the treatment of patients carrying different genotypes of hepatitis C virus (HCV) and coinfected with HIV. A Medline literature search was conducted to identify RCTs evaluating SVRs to peginterferon and interferon in HCV/HIV-coinfected patients. Six studies matched the selection criteria, and the HCV genotype of 1,717 coinfected patients was reported. For genotypes 1 or 4 HCV and HIV-coinfected patients, both types of peginterferon, α-2a and α-2b, achieved higher SVRs compared with the respective types of interferon. The SVRs achieved in patients infected with HCV genotypes 1 or 4 treated with peginterferon and ribavirin was not satisfactory in comparison with those of patients infected with HCV genotypes 2 or 3 (26% vs. 55%). The probability of achieving higher SVRs in patients when treated with peginterferon plus ribavirin increased compared with other therapies, especially for patients coinfected with HCV genotypes 1 or 4 and HIV. The likelihoods of serious adverse effects and withdrawal rates were similar. More... »

PAGES

1183-1192

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10096-008-0557-8

DOI

http://dx.doi.org/10.1007/s10096-008-0557-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1014821552

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18560911


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepacivirus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis C, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon alpha-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon-alpha", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferons", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polyethylene Glycols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recombinant Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ribavirin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Laboratory Animal Center, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Immunology and Microbiology, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
            "Laboratory Animal Center, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhao", 
        "givenName": "S.", 
        "id": "sg:person.01217761561.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217761561.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics of the First Affiliated Hospital, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Pediatrics of the First Affiliated Hospital, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cheng", 
        "givenName": "D.", 
        "id": "sg:person.0656247150.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656247150.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory Animal Center, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Laboratory Animal Center, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "E.", 
        "id": "sg:person.016446245112.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016446245112.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi\u2019an Jiaotong University, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.452438.c", 
          "name": [
            "Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi\u2019an Jiaotong University, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yu", 
        "givenName": "H.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Public Health, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Public Health, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "H.", 
        "id": "sg:person.01353407225.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353407225.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Immunology and Microbiology, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Immunology and Microbiology, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xue", 
        "givenName": "X.", 
        "id": "sg:person.0772655513.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772655513.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Immunology and Microbiology, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Immunology and Microbiology, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chu", 
        "givenName": "Y.", 
        "id": "sg:person.01132665065.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132665065.66"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2008-06-17", 
    "datePublishedReg": "2008-06-17", 
    "description": "It remains difficult to achieve high sustained response rates (SVRs) in chronic hepatitis patients coinfected with human immunodeficiency virus (HIV). The aim of this study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing peginterferon with interferon in the treatment of patients carrying different genotypes of hepatitis C virus (HCV) and coinfected with HIV. A Medline literature search was conducted to identify RCTs evaluating SVRs to peginterferon and interferon in HCV/HIV-coinfected patients. Six studies matched the selection criteria, and the HCV genotype of 1,717 coinfected patients was reported. For genotypes 1 or 4 HCV and HIV-coinfected patients, both types of peginterferon, \u03b1-2a and \u03b1-2b, achieved higher SVRs compared with the respective types of interferon. The SVRs achieved in patients infected with HCV genotypes 1 or 4 treated with peginterferon and ribavirin was not satisfactory in comparison with those of patients infected with HCV genotypes 2 or 3 (26% vs. 55%). The probability of achieving higher SVRs in patients when treated with peginterferon plus ribavirin increased compared with other therapies, especially for patients coinfected with HCV genotypes 1 or 4 and HIV. The likelihoods of serious adverse effects and withdrawal rates were similar.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10096-008-0557-8", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.4942147", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1093599", 
        "issn": [
          "0934-9723", 
          "1435-4373"
        ], 
        "name": "European Journal of Clinical Microbiology & Infectious Diseases", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "27"
      }
    ], 
    "keywords": [
      "human immunodeficiency virus", 
      "hepatitis C virus", 
      "higher SVR", 
      "HCV/HIV-coinfected patients", 
      "higher sustained response rates", 
      "sustained response rate", 
      "chronic hepatitis patients", 
      "treatment of patients", 
      "serious adverse effects", 
      "types of peginterferon", 
      "MEDLINE literature search", 
      "HIV patients", 
      "hepatitis patients", 
      "HCV genotypes", 
      "immunodeficiency virus", 
      "C virus", 
      "genotype 1", 
      "\u03b1-2a", 
      "peginterferon", 
      "\u03b1-2b", 
      "patients", 
      "response rate", 
      "genotype infections", 
      "interferon", 
      "literature search", 
      "adverse effects", 
      "ribavirin", 
      "virus", 
      "treatment", 
      "withdrawal rate", 
      "selection criteria", 
      "SVR", 
      "different genotypes", 
      "RCTs", 
      "therapy", 
      "infection", 
      "trials", 
      "genotypes", 
      "study", 
      "rate", 
      "aim", 
      "respective types", 
      "criteria", 
      "likelihood", 
      "types", 
      "effect", 
      "search", 
      "comparison", 
      "probability"
    ], 
    "name": "Peginterferon vs. interferon in the treatment of different HCV genotype infections in HIV patients", 
    "pagination": "1183-1192", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1014821552"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10096-008-0557-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18560911"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10096-008-0557-8", 
      "https://app.dimensions.ai/details/publication/pub.1014821552"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_464.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10096-008-0557-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10096-008-0557-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10096-008-0557-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10096-008-0557-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10096-008-0557-8'


 

This table displays all metadata directly associated to this object as RDF triples.

242 TRIPLES      20 PREDICATES      94 URIs      85 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10096-008-0557-8 schema:about N04b6f150093a42709b36d62a86c42266
2 N11af37ef42d34e2e89e8dfa288f8fb9c
3 N1568ff51ba9440029432615b20442324
4 N2e0f01b69b2b4373952cadc19fffeb27
5 N5cbdd6fafaf842a9b3edd85f144132e2
6 N63b115c61aaf47deaea53f5b29f1b1db
7 N7014238c2642429f9533d5777c752052
8 N78d0433cdf474d059fb6c2d7571ce86a
9 N7bc8d94d974947c8aad029c088e64949
10 N7c60e70194574fa3b3d364fa9e8f7308
11 N8c6dcdf865504be7900b507863e44898
12 Naf533355791342ee86b1f6f057db429a
13 Nbd21e7d680954bf6a6c13af8dbdbbd06
14 Nd233f5768d244475baef23f86cdeec0f
15 Nd5269294a6ca45248f0493779724c378
16 Ndff44bfd8cb942d5b0e04288c1fc3b99
17 Ne50655fe02fc428298ca5db39f494077
18 Ne902357c40b2473aa41f85b22f7f3add
19 Nec040c41c43e495f9fae08891e80b8c3
20 anzsrc-for:11
21 anzsrc-for:1103
22 anzsrc-for:1108
23 schema:author N41b2341dcc5b4f8a89fc7e896eef87c1
24 schema:datePublished 2008-06-17
25 schema:datePublishedReg 2008-06-17
26 schema:description It remains difficult to achieve high sustained response rates (SVRs) in chronic hepatitis patients coinfected with human immunodeficiency virus (HIV). The aim of this study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing peginterferon with interferon in the treatment of patients carrying different genotypes of hepatitis C virus (HCV) and coinfected with HIV. A Medline literature search was conducted to identify RCTs evaluating SVRs to peginterferon and interferon in HCV/HIV-coinfected patients. Six studies matched the selection criteria, and the HCV genotype of 1,717 coinfected patients was reported. For genotypes 1 or 4 HCV and HIV-coinfected patients, both types of peginterferon, α-2a and α-2b, achieved higher SVRs compared with the respective types of interferon. The SVRs achieved in patients infected with HCV genotypes 1 or 4 treated with peginterferon and ribavirin was not satisfactory in comparison with those of patients infected with HCV genotypes 2 or 3 (26% vs. 55%). The probability of achieving higher SVRs in patients when treated with peginterferon plus ribavirin increased compared with other therapies, especially for patients coinfected with HCV genotypes 1 or 4 and HIV. The likelihoods of serious adverse effects and withdrawal rates were similar.
27 schema:genre article
28 schema:isAccessibleForFree false
29 schema:isPartOf Nf602109a099146a08c43a8216efd42b1
30 Nf71fa68d297041af9fac2b6b8f33667b
31 sg:journal.1093599
32 schema:keywords C virus
33 HCV genotypes
34 HCV/HIV-coinfected patients
35 HIV patients
36 MEDLINE literature search
37 RCTs
38 SVR
39 adverse effects
40 aim
41 chronic hepatitis patients
42 comparison
43 criteria
44 different genotypes
45 effect
46 genotype 1
47 genotype infections
48 genotypes
49 hepatitis C virus
50 hepatitis patients
51 higher SVR
52 higher sustained response rates
53 human immunodeficiency virus
54 immunodeficiency virus
55 infection
56 interferon
57 likelihood
58 literature search
59 patients
60 peginterferon
61 probability
62 rate
63 respective types
64 response rate
65 ribavirin
66 search
67 selection criteria
68 serious adverse effects
69 study
70 sustained response rate
71 therapy
72 treatment
73 treatment of patients
74 trials
75 types
76 types of peginterferon
77 virus
78 withdrawal rate
79 α-2a
80 α-2b
81 schema:name Peginterferon vs. interferon in the treatment of different HCV genotype infections in HIV patients
82 schema:pagination 1183-1192
83 schema:productId N2641c6a26d0041349fdf48e32ca9a269
84 N264d8c8e75444e0f8edb7b3397d4f15d
85 Nae57bb8ddcbe41c9a150acd7e8ba4085
86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014821552
87 https://doi.org/10.1007/s10096-008-0557-8
88 schema:sdDatePublished 2022-09-02T15:52
89 schema:sdLicense https://scigraph.springernature.com/explorer/license/
90 schema:sdPublisher N93923db1b5194b04a8934dfd74bb1e3e
91 schema:url https://doi.org/10.1007/s10096-008-0557-8
92 sgo:license sg:explorer/license/
93 sgo:sdDataset articles
94 rdf:type schema:ScholarlyArticle
95 N04b6f150093a42709b36d62a86c42266 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Genotype
97 rdf:type schema:DefinedTerm
98 N11af37ef42d34e2e89e8dfa288f8fb9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Treatment Outcome
100 rdf:type schema:DefinedTerm
101 N1568ff51ba9440029432615b20442324 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Interferon-alpha
103 rdf:type schema:DefinedTerm
104 N2641c6a26d0041349fdf48e32ca9a269 schema:name pubmed_id
105 schema:value 18560911
106 rdf:type schema:PropertyValue
107 N264d8c8e75444e0f8edb7b3397d4f15d schema:name doi
108 schema:value 10.1007/s10096-008-0557-8
109 rdf:type schema:PropertyValue
110 N2e0f01b69b2b4373952cadc19fffeb27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Ribavirin
112 rdf:type schema:DefinedTerm
113 N2fe505d5281b40c9a035839b407e7416 rdf:first sg:person.0772655513.43
114 rdf:rest Nd2b6462ed5b544f79406542dcd154dd5
115 N41b2341dcc5b4f8a89fc7e896eef87c1 rdf:first sg:person.01217761561.81
116 rdf:rest Ne898bc9ddfdd4bd6bdb7b51010275e01
117 N5cbdd6fafaf842a9b3edd85f144132e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Middle Aged
119 rdf:type schema:DefinedTerm
120 N63b115c61aaf47deaea53f5b29f1b1db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Male
122 rdf:type schema:DefinedTerm
123 N7014238c2642429f9533d5777c752052 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Hepacivirus
125 rdf:type schema:DefinedTerm
126 N7333a601fc694956aafe1c51c89c743c rdf:first sg:person.016446245112.43
127 rdf:rest Ned510d36562c4f91b75b358c82bbff21
128 N73cf2493bd184f3daf08efce188e1180 schema:affiliation grid-institutes:grid.452438.c
129 schema:familyName Yu
130 schema:givenName H.
131 rdf:type schema:Person
132 N78d0433cdf474d059fb6c2d7571ce86a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Recombinant Proteins
134 rdf:type schema:DefinedTerm
135 N7bc8d94d974947c8aad029c088e64949 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Female
137 rdf:type schema:DefinedTerm
138 N7c60e70194574fa3b3d364fa9e8f7308 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name HIV Infections
140 rdf:type schema:DefinedTerm
141 N8c6dcdf865504be7900b507863e44898 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Randomized Controlled Trials as Topic
143 rdf:type schema:DefinedTerm
144 N93923db1b5194b04a8934dfd74bb1e3e schema:name Springer Nature - SN SciGraph project
145 rdf:type schema:Organization
146 Nae57bb8ddcbe41c9a150acd7e8ba4085 schema:name dimensions_id
147 schema:value pub.1014821552
148 rdf:type schema:PropertyValue
149 Naf533355791342ee86b1f6f057db429a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Antiviral Agents
151 rdf:type schema:DefinedTerm
152 Nbd21e7d680954bf6a6c13af8dbdbbd06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Hepatitis C, Chronic
154 rdf:type schema:DefinedTerm
155 Nd233f5768d244475baef23f86cdeec0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Interferons
157 rdf:type schema:DefinedTerm
158 Nd2b6462ed5b544f79406542dcd154dd5 rdf:first sg:person.01132665065.66
159 rdf:rest rdf:nil
160 Nd5269294a6ca45248f0493779724c378 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Humans
162 rdf:type schema:DefinedTerm
163 Ndff44bfd8cb942d5b0e04288c1fc3b99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Polyethylene Glycols
165 rdf:type schema:DefinedTerm
166 Ne50655fe02fc428298ca5db39f494077 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Interferon alpha-2
168 rdf:type schema:DefinedTerm
169 Ne898bc9ddfdd4bd6bdb7b51010275e01 rdf:first sg:person.0656247150.94
170 rdf:rest N7333a601fc694956aafe1c51c89c743c
171 Ne902357c40b2473aa41f85b22f7f3add schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Adult
173 rdf:type schema:DefinedTerm
174 Nec040c41c43e495f9fae08891e80b8c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Drug Therapy, Combination
176 rdf:type schema:DefinedTerm
177 Nec95938e98b848cd807889b838df6f1c rdf:first sg:person.01353407225.43
178 rdf:rest N2fe505d5281b40c9a035839b407e7416
179 Ned510d36562c4f91b75b358c82bbff21 rdf:first N73cf2493bd184f3daf08efce188e1180
180 rdf:rest Nec95938e98b848cd807889b838df6f1c
181 Nf602109a099146a08c43a8216efd42b1 schema:volumeNumber 27
182 rdf:type schema:PublicationVolume
183 Nf71fa68d297041af9fac2b6b8f33667b schema:issueNumber 12
184 rdf:type schema:PublicationIssue
185 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
186 schema:name Medical and Health Sciences
187 rdf:type schema:DefinedTerm
188 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
189 schema:name Clinical Sciences
190 rdf:type schema:DefinedTerm
191 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
192 schema:name Medical Microbiology
193 rdf:type schema:DefinedTerm
194 sg:grant.4942147 http://pending.schema.org/fundedItem sg:pub.10.1007/s10096-008-0557-8
195 rdf:type schema:MonetaryGrant
196 sg:journal.1093599 schema:issn 0934-9723
197 1435-4373
198 schema:name European Journal of Clinical Microbiology & Infectious Diseases
199 schema:publisher Springer Nature
200 rdf:type schema:Periodical
201 sg:person.01132665065.66 schema:affiliation grid-institutes:grid.43169.39
202 schema:familyName Chu
203 schema:givenName Y.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132665065.66
205 rdf:type schema:Person
206 sg:person.01217761561.81 schema:affiliation grid-institutes:grid.43169.39
207 schema:familyName Zhao
208 schema:givenName S.
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217761561.81
210 rdf:type schema:Person
211 sg:person.01353407225.43 schema:affiliation grid-institutes:grid.43169.39
212 schema:familyName Yang
213 schema:givenName H.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353407225.43
215 rdf:type schema:Person
216 sg:person.016446245112.43 schema:affiliation grid-institutes:grid.43169.39
217 schema:familyName Liu
218 schema:givenName E.
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016446245112.43
220 rdf:type schema:Person
221 sg:person.0656247150.94 schema:affiliation grid-institutes:grid.43169.39
222 schema:familyName Cheng
223 schema:givenName D.
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656247150.94
225 rdf:type schema:Person
226 sg:person.0772655513.43 schema:affiliation grid-institutes:grid.43169.39
227 schema:familyName Xue
228 schema:givenName X.
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772655513.43
230 rdf:type schema:Person
231 grid-institutes:grid.43169.39 schema:alternateName Department of Immunology and Microbiology, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
232 Department of Pediatrics of the First Affiliated Hospital, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
233 Department of Public Health, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
234 Laboratory Animal Center, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
235 schema:name Department of Immunology and Microbiology, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
236 Department of Pediatrics of the First Affiliated Hospital, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
237 Department of Public Health, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
238 Laboratory Animal Center, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
239 rdf:type schema:Organization
240 grid-institutes:grid.452438.c schema:alternateName Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, 710061, Shaanxi, China
241 schema:name Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, 710061, Shaanxi, China
242 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...